title: Human proinsulin. Does it improve the treatment of type I diabetics?
authors.affiliation: Medizinische Klinik Innenstadt, Universität München, Germany.
authors.forename: M M
authors.initials: MM
authors.lastname: Landgraf-Leurs
authors.forename: R
authors.initials: R
authors.lastname: Hörmann
authors.forename: A
authors.initials: A
authors.lastname: Loy
authors.forename: A
authors.initials: A
authors.lastname: König
authors.forename: S
authors.initials: S
authors.lastname: Kammerer
authors.forename: R
authors.initials: R
authors.lastname: Landgraf
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006023:Glycoproteins; D006728:Hormones / Q000097:blood; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D007700:Kinetics; D008297:Male; D011384:Proinsulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D000093422:Glycated Serum Proteins
chemical_list: D001786:Blood Glucose; D001798:Blood Proteins; D006023:Glycoproteins; D006728:Hormones; D007328:Insulin; D011994:Recombinant Proteins; D011384:Proinsulin; D000093422:Glycated Serum Proteins